Risk-Based Selection for Active Surveillance: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Initiative-Reference-Cited by-同舟云学术

Risk-Based Selection for Active Surveillance: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Initiative

Published:2021-07 Issue:1 Volume:206 Page:62-68
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Bruinsma Sophie M.¹,Nieboer Daan¹²^ORCID,Roobol Monique J.¹,Bangma Chris H.¹,Verbeek Jan F. M.¹,Gnanapragasam Vincent³,Van Hemelrijck Mieke⁴,Frydenberg Mark⁵⁶,Lee Lui-Shiong⁷⁸,Valdagni Riccardo⁹,Logothetis Christopher¹⁰,Steyerberg Ewout W.²¹¹

Affiliation:

1. Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands

2. Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands

3. Academic Urology Group, Department of Surgery & Oncology, University of Cambridge, Cambridge, United Kingdom

4. Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom

5. Department of Urology, Cabrini Institute, Cabrini Health, Melbourne, Australia

6. Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia

7. Department of Urology, Sengkang General Hospital, Singapore, Singapore

8. Department of Urology, Singapore General Hospital, Singapore, Singapore

9. Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Prostate Cancer Program, Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy

10. MD Anderson Cancer Centre, Houston, Texas

11. Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer—A Report of a Movember International Consensus Meeting;European Urology Oncology;2023-04

2. Low risk is low risk, regardless of race or ethnicity: Outcomes of prostate cancer active surveillance and factors associated with reclassification in a racially diverse cohort;Urologic Oncology: Seminars and Original Investigations;2023-04

3. Prostate volume is an independent predictive factor in selecting low-risk prostate patients for active surveillance;Frontiers in Urology;2022-11-23

4. No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance;Scientific Reports;2022-04-25

5. Two Decades of Active Surveillance for Prostate Cancer in a Single-Center Cohort: Favorable Outcomes after Transurethral Resection of the Prostate;Cancers;2022-01-12